Recursion's technology works by generating millions of cellular images and using AI-based software as a way to analyze the data set and screen potential therapeutic compounds against a variety of diseased cells.
The deal comes days after Gilead partnered on clinical development in NASH with Denmark's Novo Nordisk, and two months after the high-profile failure of a Phase III study in the disease.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Daphne Zoller, the former chief computing officer of Alphabet's anti-aging business, Calico Labs, also cofounded Coursera in 2012.